Physician profile
Leah E Hulse
NPI 1285117820
$867.87
in general payments reported to CMS, 2019-2025
15 companies · $127 in 2025
The $127 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $121 · 2022: $190 · 2023: $251 · 2024: $179 · 2025: $127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $557.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $557.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $229.89 | 2022-2024 | Wakix |
| Insmed, INC. | $129.27 | 2024-2025 | Arikayce, Brinsupri |
| Astrazeneca Pharmaceuticals LP | $83.08 | 2022-2025 | Fasenra, Tezspire |
| Jazz Pharmaceuticals INC. | $81.87 | 2021-2023 | |
| Glaxosmithkline, LLC. | $80.38 | 2021-2022 | |
| Mylan Specialty L.P. | $67.77 | 2021-2023 | Yupelri |
| Regeneron Healthcare Solutions, INC. | $42.10 | 2024 | Dupixent |
| Boehringer Ingelheim Pharmaceuticals, INC. | $37.69 | 2022 | |
| Amgen INC. | $21.86 | 2025 | Tezspire |
| Axsome Therapeutics, INC. | $19.67 | 2023 | Sunosi |
| Philips North America LLC | $18.09 | 2024 | (Ak6) Vest Therapy |
| Inogen, INC. | $14.82 | 2022 | |
| Vanda Pharmaceuticals INC. | $14.76 | 2021 | |
| Grifols USA, LLC | $13.32 | 2021 | |
| Genzyme Corporation | $13.30 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leah Hulse listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.